| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |